Home » Medtronic Launches Trial for Self-Expanding Stent
Medtronic Launches Trial for Self-Expanding Stent
Medtronic has begun enrolling patients in a clinical trial evaluating its self-expanding Complete SE stent for the treatment of peripheral arterial disease in the superficial femoral artery. Approved by the FDA under an investigational device exemption, the multicenter, single-arm trial will enroll 178 subjects at 30 international sites. The study has primary endpoints of major adverse events and patency of the stent at 12 months, the company said.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May